Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,323,877
+$105,717 QoQ
Shares Held
5,261
-6.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#2,293
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 27%
Shared 73%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SOMERVILLE KURT F holds $31,801,956 across 8 Drug Manufacturers - General names. ABBV ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
58,877 | $14,952,986 | |
| 2 | LLY |
ELI LILLY & Co
|
9,217 | $11,055,144 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,539 | $1,996,761 | |
| 4 | NVS |
Novartis AG
|
10,438 | $1,635,841 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
5,261 | $1,323,877 | |
| 6 | AMGN |
Amgen Inc
|
1,057 | $382,760 | |
| 7 | NVO |
Novo Nordisk A S
|
4,825 | $231,310 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,875 | $223,277 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,323,877 | 5,261 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,218,160 | 5,601 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,441,085 | 6,307 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,657,129 | 7,157 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,356,323 | 7,307 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,536,198 | 7,332 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,302,895 | 7,332 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,453,846 | 7,362 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,278,165 | 7,452 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,361,560 | 7,477 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,158,708 | 7,477 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,129,576 | 7,578 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,054,396 | 7,826 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,601,235 | 16,322 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,676,583 | 16,562 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $2,222,785 | 16,562 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,581,051 | 16,852 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,953,318 | 18,218 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $2,681,732 | 19,806 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,142,944 | 19,866 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,260,234 | 20,066 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,248,919 | 20,781 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,176,751 | 20,315 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,779,389 | 20,315 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $2,196,776 | 22,375 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,567,607 | 20,575 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||